Impact of COVID-19 on patients with PiZZ alpha1-antitrypsin deficiency: the IMCA1 study revisited.

Author
Chorostowska-Wynimko, Joanna
Corsico, Angelo
Esquinas, Cristina
Mcelvaney, Gerard
Sark, Annelot
Sucena, Maria
Tanash, Hanan
Turner, Alice
Miravitlles, Marc
PARR, DAVID cc
Publication date
2023-10-27
Subject
Respiratory medicine

Metadata
Show full item record
Abstract
IMCA1 concluded that a poor outcome in patients with an AAT level <60mg/dl related to non-respiratory comorbidities more than to markers of respiratory disease1, but deaths only occurred in PiZZ patients.
Citation
European Respiratory Journal 2023 62: PA5107
Type
Conference Output
Handle
http://hdl.handle.net/20.500.14200/2761
DOI
10.1183/13993003.congress-2023.pa5107
Journal
European Respiratory Journal
Publisher
European Respiratory Society
Collections